ISEC Healthcare Ltd. (SGX:40T)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.2900
-0.0050 (-1.69%)
At close: Jul 27, 2026

ISEC Healthcare Cash Flow Statement

Millions SGD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
13.1213.3712.8212.9612.526.91
Depreciation & Amortization
4.914.854.323.893.453.23
Other Amortization
0.070.070.020.010.010.02
Loss (Gain) From Sale of Assets
-----0-
Asset Writedown & Restructuring Costs
--1.530.010.020
Loss (Gain) From Sale of Investments
----0.16-
Loss (Gain) on Equity Investments
----00.01
Stock-Based Compensation
--0.060.090.030.07
Provision & Write-off of Bad Debts
0.090.10.040.020.060
Other Operating Activities
-0.51-0.40.18-0.051.070.08
Change in Accounts Receivable
0.12-0.67-0.620.10.54-0.57
Change in Inventory
-0.23-0.21-0.14-0.47-0.50.02
Change in Accounts Payable
-1.311.93-0.480.650.522.55
Change in Other Net Operating Assets
-0.07-0.07-0.09-0.04-0.03-0.03
Operating Cash Flow
16.1918.9717.6417.1717.8512.3
Operating Cash Flow Growth
-12.22%7.55%2.74%-3.79%45.11%56.21%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-19.59-19.55-11.78-3.42-5.71-0.73
Sale of Property, Plant & Equipment
----0-
Cash Acquisitions
---1.03-3.21-6.11-1.77
Sale (Purchase) of Intangibles
-0.04-0.07-0.29-0.1-0-0.06
Other Investing Activities
0.390.350.320.290.220.22
Investing Cash Flow
-19.25-19.26-12.78-6.43-11.6-2.34

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--0.471.18--
Long-Term Debt Issued
-15.480.030.51--
Total Debt Issued
15.5815.480.51.69--
Long-Term Debt Repaid
--3.17-2.77-2.57-2.61-2.43
Net Debt Issued (Repaid)
12.5912.31-2.27-0.88-2.61-2.43
Issuance of Common Stock
--0.210.65-0.01
Common Dividends Paid
-4.03-4.03-6.62-10.54-4.4-8.53
Other Financing Activities
-0.69-0.55-0.46-0.54-0.16-0.36
Financing Cash Flow
7.877.73-9.13-11.31-7.17-11.3

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.620.450.77-0.66-0.94-0.3
Net Cash Flow
5.447.88-3.49-1.23-1.86-1.63

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-3.4-0.575.8613.7512.1411.57
Free Cash Flow Growth
---57.38%13.33%4.91%108.04%
Free Cash Flow Margin
-4.25%-0.73%7.90%19.65%19.28%28.58%
Free Cash Flow Per Share
-0.01-0.000.010.020.020.02
Levered Free Cash Flow
-5.77-4.033.829.8311.358.74
Unlevered Free Cash Flow
-5.38-3.644.1810.2311.78.99

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.820.670.550.550.430.36
Cash Income Tax Paid
4.975.024.454.733.462.21
Change in Working Capital
-1.480.99-1.320.240.541.98